Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).

NCT05161702 is registered in ClinicalTrials.gov with SCF Pharma as lead sponsor.

NCT NCT05161702
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05161702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).
Lead sponsor
SCF Pharma
Phase
Observational
Overall status
Recruiting
Start date
March 12, 2019
Completion date
January 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

reduction of cell proliferation, resolution of inflammation